Citadel Advisors
IDNA icon

Citadel Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Citadel Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724K Buy
+21,463
New +$644K ﹤0.01% 8992
2026
Q1 		– Sell
-11,490
Closed -$301K – 13547
2025
Q4 		$301K Sell
11,490
-12,759
-53% -$328K ﹤0.01% 10145
2025
Q3 		$573K Buy
+24,249
New +$536K ﹤0.01% 8802
2025
Q1 		– Sell
-17,020
Closed -$385K – 14972
2024
Q4 		$385K Buy
+17,020
New +$409K ﹤0.01% 9133
2024
Q3 		– Sell
-39,045
Closed -$903K – 14674
2024
Q2 		$903K Buy
39,045
+17,658
+83% +$413K ﹤0.01% 6795
2024
Q1 		$515K Sell
21,387
-17,783
-45% -$417K ﹤0.01% 8324
2023
Q4 		$901K Buy
39,170
+18,361
+88% +$369K ﹤0.01% 6881
2023
Q3 		$423K Buy
+20,809
New +$467K ﹤0.01% 8427
2023
Q1 		– Sell
-15,654
Closed -$394K – 15058
2022
Q4 		$394K Sell
15,654
-21,473
-58% -$577K ﹤0.01% 8744
2022
Q3 		$980K Buy
+37,127
New +$1.15M ﹤0.01% 7042
2022
Q2 		– Sell
-16,584
Closed -$571K – 13416
2022
Q1 		$571K Sell
16,584
-66,870
-80% -$2.36M ﹤0.01% 9076
2021
Q4 		$3.66M Buy
83,454
+50,199
+151% +$2.38M ﹤0.01% 4936
2021
Q3 		$1.69M Buy
33,255
+4,240
+15% +$221K ﹤0.01% 6800
2021
Q2 		$1.51M Sell
29,015
-4,447
-13% -$209K ﹤0.01% 7305
2021
Q1 		$1.53M Buy
+33,462
New +$1.63M ﹤0.01% 7046
2020
Q4 		– Sell
-23,976
Closed -$934K – 11187
2020
Q3 		$934K Sell
23,976
-2,675
-10% -$103K ﹤0.01% 6154
2020
Q2 		$1.01M Buy
+26,651
New +$900K ﹤0.01% 5805

Other funds holding IDNA

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
TF
Trek Financial Scottsdale, Arizona $2.01B AUM 53.49% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's IDNA Position: Q2 2026 in Review

Citadel Advisors opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 21,463 shares worth $724K. The stake represents ﹤0.01% of the portfolio and ranks #8992 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in IDNA as recently as Q4 2025.

Citadel Advisors first reported a position in IDNA in Q2 2020 and has held it in 17 quarters since. The position peaked at $3.66M in Q4 2021. 66 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Citadel Advisors held 21,463 shares of iShares Genomics Immunology and Healthcare ETF worth $724K as of Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new Citadel Advisors position in Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8992 holding.
  • Citadel Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q2 2020 and has held it in 17 quarters since.
  • Citadel Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $3.66M in Q4 2021.
  • 66 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.